What antibiotic groups are used for targeted therapy of Aeromonas infections?

Targeted therapy for Aeromonas infections utilizes antibiotics while accounting for their intrinsic resistance to beta-lactams. While blood agar with ampicillin is used in microbiological diagnostics and selection, clinical management relies on appropriate targeted antimicrobial therapy.

What is the antigenic structure of Aeromonas?

The antigenic structure of Aeromonas is classified based on the O-antigen, encompassing 44 serogroups. Human-pathogenic serogroups include O11, O16, and O34.

What is the mechanism of action of aerolysin on host cells?

Aerolysin is listed among the cytotoxins of Aeromonas and functions as a toxic virulence factor. The detailed intracellular mechanism of action on host cells is not elaborated in the primary sources.

Which bacteria must be differentiated from Aeromonas during the diagnosis of acute intestinal infections?

Differential diagnosis of acute bacterial intestinal infections includes pathogenic Gram-negative enterobacteria (Salmonella, Shigella, Campylobacter, Escherichia, Yersinia), opportunistic flora (Klebsiella, Proteus, Clostridium, Enterobacter, Pseudomonas aeruginosa), as well as emerging or established pathogens such as Aeromonas, Plesiomonas, and halophilic vibrios.

Home › Microbiology › Aeromonas: Morphology, Pathogenesis and Clinical Features

Aeromonas

For medical students2 min readUpdated 2026-10-10

Aeromonas species are Gram-negative rod-shaped bacteria whose natural habitat is aquatic ecosystems. They are emerging pathogens responsible for human infections, including gastroenteritis, wound infections, and septicemia.

MorphologyGram-negative rods with a polar flagellum and capsule

EcologyAquatic ecosystems

ResistanceIntrinsic resistance to beta-lactams

EnzymesOxidase- and catalase-positive

Morphology and Cultural Characteristics

The genus Aeromonas comprises 12 species, three of which are clinically significant for humans: A. hydrophila, A. caviae, and A. veronii (subspecies sobria).

These are Gram-negative motile rods possessing a capsule and a single polar flagellum. Interestingly, when cultured on solid nutrient media, certain species can form entire tufts of flagella.

Regarding respiration, these bacteria are facultative anaerobes. They are non-fastidious and grow exceptionally well on standard nutrient media as well as in alkaline peptone water.

Growth characteristics on differential media:

On blood agar, they form colonies surrounded by a zone of beta-hemolysis.
On lactose-containing media, they appear as lactose-negative organisms.

Aeromonas species exhibit intrinsic resistance to beta-lactams; therefore, blood agar supplemented with ampicillin (15 mg/L) is used for their selective isolation.

Pathogenicity Factors

The pathogenic potential of Aeromonas is determined by a complex of structural and secreted substances. Attachment to host cells (erythrocyte and enterocyte carbohydrate receptors) is mediated by adhesins.

Toxic substances and aggressive enzymes include:

Toxins:
Cytotoxins: aerolysin and cytolysin.
Enterotoxins: heat-labile and heat-stable. Notably, the heat-stable enterotoxin shares antigenic similarity with cholera toxin.
Hemolysins.
Aggressive enzymes:
Heat-stable serine protease.
Metalloproteases (including phospholipase and chitinase).

Microbiological Diagnostics

The primary diagnostic method for Aeromonas infections is bacterial culture. The inoculation algorithm depends on the specimen type:

Stool: the specimen is first inoculated into an enrichment broth (alkaline peptone water). After 24 hours, subculturing is performed onto a selective medium — blood agar with ampicillin.
Wound exudate: parallel inoculation is performed onto blood agar with ampicillin and into alkaline peptone water.

For further identification, colonies surrounded by a zone of hemolysis are selected. The bacteria are confirmed using catalase and oxidase tests (Aeromonas are positive for both). Final biochemical identification is performed using standard test systems designed for Enterobacteriaceae.

Epidemiology and Treatment

Infections caused by Aeromonas are classified as emerging. The reservoir and natural habitat for these bacteria is water.

In humans, infection can manifest in several forms:

Gastroenteritis (following ingestion of the pathogen via the GI tract).
Wound infections (following contact of damaged skin with contaminated water).
Septicemia (a severe generalized form occurring predominantly in immunocompromised individuals).

Treatment relies on targeted antimicrobial therapy (taking into account their intrinsic resistance to beta-lactams).

Mnemonic

Remember the triad: Aeromonas — Water — Ampicillin. They live in water, and media with ampicillin is always used for laboratory isolation due to their intrinsic beta-lactam resistance.

Frequently asked questions

What antibiotic groups are used for targeted therapy of Aeromonas infections?: Targeted therapy for Aeromonas infections utilizes antibiotics while accounting for their intrinsic resistance to beta-lactams. While blood agar with ampicillin is used in microbiological diagnostics and selection, clinical management relies on appropriate targeted antimicrobial therapy.
What is the antigenic structure of Aeromonas?: The antigenic structure of Aeromonas is classified based on the O-antigen, encompassing 44 serogroups. Human-pathogenic serogroups include O11, O16, and O34.
What is the mechanism of action of aerolysin on host cells?: Aerolysin is listed among the cytotoxins of Aeromonas and functions as a toxic virulence factor. The detailed intracellular mechanism of action on host cells is not elaborated in the primary sources.
Which bacteria must be differentiated from Aeromonas during the diagnosis of acute intestinal infections?: Differential diagnosis of acute bacterial intestinal infections includes pathogenic Gram-negative enterobacteria (Salmonella, Shigella, Campylobacter, Escherichia, Yersinia), opportunistic flora (Klebsiella, Proteus, Clostridium, Enterobacter, Pseudomonas aeruginosa), as well as emerging or established pathogens such as Aeromonas, Plesiomonas, and halophilic vibrios.

Go deeper

Structure and mechanisms of action of aerolysin and cytolysin.
Antigenic similarity between the Aeromonas heat-stable enterotoxin and cholera toxin.
Application of Enterobacteriaceae test systems in the diagnosis of non-fermenting and other Gram-negative bacteria.
The role of chitinase and phospholipase as bacterial virulence factors.
Mechanisms of intrinsic resistance to beta-lactam antibiotics in Aeromonas.